Prevention of heart failure progression: current approaches

被引:0
|
作者
Lechat, P [1 ]
机构
[1] Pitie Salpetriere Hosp, Dept Pharmacol, F-7513 Paris, France
关键词
heart failure; compensatory mechanisms; sympathetic nervous system; renin-angiotensin-aldosterone system; diuretics; ACE inhibitors; alpha- and beta-adrenergic blockers;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure results from damage and stress to the myocardium whatever the aetiology. An increase in stress by cardiac overload is initially overcome by compensatory mechanisms that maintain blood pressure through a combination of the sympathetic nervous system and the renin-angiotensin-aldosterone system. These mechanisms may also alter myocyte function and induce progressive cell death and replacement by fibrous tissue. Disease therapy must reduce cardiac loading and avoid blood pressure control by mechanisms that have deleterious effects. Therapy includes diuretics, vasodilators and alpha-and beta-adrenergic blockade. Complete blockade of all receptors involved in the adverse effects of neurohormonal stimulation might represent an ultimate therapy objective, and improve subsequent prognosis. Large clinical trials are in progress to determine the therapy of choice in the prevention of progression of heart failure.
引用
收藏
页码:B12 / B18
页数:7
相关论文
共 50 条
  • [1] Diuretic Therapy in Heart Failure - Current Approaches
    Casu, Gavino
    Merella, Pierluigi
    EUROPEAN CARDIOLOGY REVIEW, 2015, 10 (01) : 42 - 47
  • [2] Mind-body approaches in heart failure prevention
    Binkley P.F.
    Current Cardiovascular Risk Reports, 2016, 10 (1)
  • [3] Acute decompensated heart failure: current pharmacological approaches
    Pascual-Figal, Domingo A.
    Pastor-Perez, Francisco
    Caballero, Luis
    Garrido, Iris P.
    Teresa Perez-Martinez, Maria
    RESEARCH REPORTS IN CLINICAL CARDIOLOGY, 2014, 5 : 227 - 236
  • [4] Interruption of the progression of heart failure: Are ACE inhibitors the solution?
    Coats, A
    CARDIOLOGY, 1996, 87 : 11 - 15
  • [5] Current approaches to preventing heart failure readmissions and decompensated disease
    Mace, Matthew
    Lidstromer, Niklas
    MINERVA CARDIOLOGY AND ANGIOLOGY, 2024, 72 (05) : 535 - 543
  • [6] Consensus statement on the current pharmacological prevention and management of heart failure
    Sindone, Andrew P.
    De Pasquale, Carmine
    Amerena, John
    Burdeniuk, Christine
    Chan, Alicia
    Coats, Andrew
    Hare, David L.
    Macdonald, Peter
    Sverdlov, Aaron
    Atherton, John J.
    MEDICAL JOURNAL OF AUSTRALIA, 2022, 217 (04) : 212 - 217
  • [7] PROGRESSION OF CHRONIC HEART FAILURE: PROGNOSTIC CRITERIA AND NON-DRUG PREVENTION
    Kurlyanskaya, E. R.
    Denisevich, T. L.
    Mrochek, A. G.
    KARDIOLOGIYA, 2019, 59 (04) : 26 - 32
  • [8] Atrial fibrillation and heart failure: A contemporary review of current management approaches
    Lee, Justin Z.
    Cha, Yong-Mei
    HEART RHYTHM O2, 2021, 2 (06): : 762 - 770
  • [9] Prevention of heart failure
    Bansal, Darpan
    Chahoud, Georges
    Smith, Eugene S.
    Mehta, Jawahar L.
    CURRENT OPINION IN CARDIOLOGY, 2006, 21 (05) : 510 - 516
  • [10] Prevention of heart failure
    Baker, DW
    JOURNAL OF CARDIAC FAILURE, 2002, 8 (05) : 333 - 346